J&J says Darzalex, Carvykti drive Q1 pharma sales growth while medtech looms large
Johnson & Johnson released its first quarter financial report Monday morning, highlighting a sales growth of 2.3% to $21.4 billion and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
